Heart Screening Articles & Analysis
2 news found
Paris, July 26, 2021 – 6:00 pm CEST CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announces the first implant of its Aeson® bioprosthetic artificial ...
ByCarmat
Used by more than 30 countries, the ABBOTT PRISM system is used to screen the majority of the blood supply in the United States and around the world. ...